Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit
1 other identifier
observational
106
1 country
1
Brief Summary
Substance use disorder (SUD) is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms. Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs. This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2023
CompletedFirst Posted
Study publicly available on registry
March 21, 2023
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2025
CompletedApril 13, 2026
June 1, 2025
12 months
February 27, 2023
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
To identify the sociodemographic characteristics of patients with substance use disorder attending addiction treatment unit.
1. Sociodemographic characteristics with a special prepared survey that includes: * Personal information, and socioeconomic status.(Age, gender, marital status, work, income, educational level, ...etc) * Previous admissions/trials for detox.(number of previous admissions/trials detox, where they were, maximum abstinence time, and the withdrawal symptoms the patient had) * Medical, psychological, social, financial, and legal aspects of addiction. * Adverse life events dating before starting addiction. * Detailed description of substance(s) used.( Substances used, doses, route of administration, when, where, and with whom he prefers taking the drug) 2. Psychiatric interview.
One week
To identify personality traits of patients with substance use disorder attending addiction treatment unit.
Data about personality traits of patients with substance use disorder will be obtained through: 1. Psychiatric interview. 2. The Symptom Checklist-90-Revised (SCL-90-R). 3. The Structured Interview for the Five-Factor Model of Personality (SIFFM). 4. Addiction severity Index (ASI).
One week
To identify patterns of substance abuse among patients with substance use disorder attending addiction treatment unit.
Data about patterns of substance abuse will be gathered through: 1. Psychiatric interview. 2. Addiction Severity Index (ASI). 3. Urine Drug Screen.
One week
Interventions
Counselling patients, providing supportive psychotherapy to help them detox their illicit drug usage, and help them rehabilitate again into society.
Eligibility Criteria
Patients with substance use disorder, based on DSM-5 criteria, who are admitted to the addiction management unit of Assiut University Hospital.
You may qualify if:
- All patients with substance use disorder who are admitted to the addiction treatment unit.
- Accept participating into the study.
You may not qualify if:
- Patients refuse participating in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University Hospital
Asyut, Assiut Governorate, Egypt
Related Publications (4)
Loffredo CA, Boulos DN, Saleh DA, Jillson IA, Garas M, Loza N, Samuel P, Shaker YE, Ostrowski MJ, Amr S. Substance use by Egyptian youth: current patterns and potential avenues for prevention. Subst Use Misuse. 2015 Apr;50(5):609-18. doi: 10.3109/10826084.2014.997391. Epub 2015 Jan 28.
PMID: 25629955BACKGROUNDConnery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance Use Disorders in Global Mental Health Delivery: Epidemiology, Treatment Gap, and Implementation of Evidence-Based Treatments. Harv Rev Psychiatry. 2020 Sep/Oct;28(5):316-327. doi: 10.1097/HRP.0000000000000271.
PMID: 32925514BACKGROUNDDarweesh, A. E., Agban, M., Mohammed, M. H., & Gabra, R. H. (2020). Association between opioid use disorder (tramadol) and serum level of interleukin-2. Middle East Current Psychiatry, 27(1). https://doi.org/10.1186/s43045-020-00037-w
BACKGROUNDRabie, M., Shaker, N.M., Gaber, E. et al. Prevalence updates of substance use among Egyptian adolescents. Middle East Curr Psychiatry 27, 4 (2020). https://doi.org/10.1186/s43045-019-0013-8
BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alaa El Din M. Darweesh, Prof.
Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University
- STUDY DIRECTOR
Romany H. Gabra, Dr
Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident of Neurology and Psychiatry, Assiut University Hospital
Study Record Dates
First Submitted
February 27, 2023
First Posted
March 21, 2023
Study Start
April 1, 2024
Primary Completion
March 31, 2025
Study Completion
November 10, 2025
Last Updated
April 13, 2026
Record last verified: 2025-06